Real world study on first-line and sequential treatment with Osimertinib of EGFR mutant patients with advanced NSCLC
Zhang Jingli
Zheng Zhihui
Yang Lianren
Machine-generated Keywords：
Publication Date：2022-08-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 277-279 )